PredictRx is a pioneering in-vitro diagnostic platformA drug sensitivity test for cancer therapies using cell culture models to predict drug response. LINK developed the global commercialisation plan for clinical application and translational research. We set up and commissioned a reference lab in India as part of the global reach plan. We established a sales channel in the UK, South Africa, and the Scandinavian region, ultimately positioning Imagen Therapeutics for its successful exit strategy.